Antibody-Based Therapy for Transplantation-Eligible Patients with Multiple Myeloma  New England Journal of Medicine. 2024;390(4):368-369
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38265649

Anti-GABA(A) receptor encephalitis 14 months after allogeneic haematopoietic stem-cell transplant for acute myeloid leukaemia  Lancet. 2024;403(10425):469-470
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38309783

Association of arbitrary prescribing behavior to costly drug expenditures: a pharmacoeconomic study in primary care  Postgraduate Medical Journal. 2023;100(1179):36-41
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37827534

Bilateral Adrenal Infarction That Developed in Latent Essential Thrombocythemia  Internal Medicine. 2024;63(3):419-423
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37344430

Case 37-2023: A 29-Year-Old Man with Sickle Cell Disease and Right Hip Pain  New England Journal of Medicine. 2023;389(22):2088-2096
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38048191

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease  New England Journal of Medicine. 2024;390(4):326-337
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38078508

Clinical features of systemic lupus erythematosus patients with splenomegaly: focussed on the cytopenias  Internal Medicine Journal. 2023;53(12):2341-2345
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38130048

Complement in human disease: approved and up-and-coming therapeutics  Lancet. 2024;403(10424):392-405
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37979593

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma  New England Journal of Medicine. 2024;390(4):301-313
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38084760

Donor Lymphocyte Infusion for Relapsed Acute Leukemia or Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation: A Single-Institute Retrospective Analysis  Internal Medicine. 2024;63(2):197-205
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37225485

Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals  Internal Medicine. 2023;62(24):3631-3636
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37121750

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial  Lancet. 2024;403(10423):249-260
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38048786

Methemoglobinemia Outbreak in a Neonatal ICU and Maternity Ward  New England Journal of Medicine. 2023;389(25):2395-2397
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38118033

Papular-Purpuric “Gloves and Socks” Syndrome in Parvovirus B19 Infection  New England Journal of Medicine. 2024;390(2):165
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38197819

Pediatric sickle cell disease: A case for improved clinician-family partnerships  Journal of Hospital Medicine. 2024;19(2):146-148
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38017233

The promise of genetic therapies in sickle cell disease  Lancet. 2023;402(10419):2265
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38103934

Pulmonary Tumor Thrombotic Microangiopathy Caused by Metastatic Ovarian Cancer: An Antemortem Diagnosis with Pulmonary Aspiration Cytopathology  Internal Medicine. 2023;62(24):3649-3655
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37121751

Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study  Lancet. 2024;403(10423):271-281
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38071986

Sickle Cell Disease Approvals Include First CRISPR Gene Editing Therapy  JAMA. 2024;331(4):280
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38170544

Sodium-glucose cotransporter-2 inhibitor-associated erythrocytosis: A retrospective cohort study  Journal of Internal Medicine. 2024;295(1):103-105
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37729395

Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with FLT3-ITD: A multicenter phase 2 study  Journal of Internal Medicine. 2024;295(2):216-228
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37899297

Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response  Journal of Internal Medicine. 2024;295(2):229-241
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=37953670

Splenectomy reappraised: Bridging the gap in immune cytopenia treatment paradigms  Journal of Internal Medicine. 2024;295(2):120-122
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38044059

Telomerase inhibition in haematological neoplasms-are we ready for primetime?  Lancet. 2024;403(10423):220-222
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38048790

When I use a word . . . Lexicographic anniversaries in 2024-anaemia  BMJ. 2024;384:q160
https://pubmed.ncbi.nlm.nih.gov/?otool=iaufhhslib&term=38242588